Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Discover a robust Lewis acid-catalyzed method for preparing 3-allyl-3-hydroxyoxindole intermediates. Enhance supply chain reliability and reduce manufacturing costs.
Patent CN116655582A reveals a novel route for sanguinarine intermediates. Offers high purity, reduced catalyst usage, and scalable manufacturing for pharmaceutical supply chains globally.
Patent CN108640884B details a cost-effective 2-morpholinone synthesis. Discover high-purity pharmaceutical intermediates and scalable manufacturing solutions.
Novel patent CN113683574B enables high-purity synthesis for HBV intermediates with optimized supply chain reliability and cost efficiency.
Patent CN109438416B details a 4-step route to TPCA-1 using thiourea and cyclopropane derivatives, offering higher yields and milder conditions for pharmaceutical manufacturing.
Patent CN111377867B discloses a novel route for 2-(1-alkyl-1H-pyrazol-4-yl)morpholine. Enables cost reduction in kinase inhibitor manufacturing with scalable, mild conditions.
Patent CN1166672C details a novel Ru-H4-BINAP-diamine complex for asymmetric hydrogenation, offering high enantioselectivity and cost-effective manufacturing for chiral alcohol intermediates.
This patent details a novel silver-catalyzed route for 3-isocoumarin-based chromones, offering mild conditions and high yields for scalable pharmaceutical intermediate manufacturing.
Patent CN112010913B reveals a scalable MgCl2-mediated demethylation for 4-deoxy daunorubicin intermediates, offering reduced impurities and enhanced supply chain reliability for pharmaceutical manufacturers.
Patent CN102978267B reveals advanced enzymatic glutathione production with ATP regeneration. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel iodination route for Crisaborole key intermediate reduces EHS risks and improves yield. Ideal for reliable pharmaceutical intermediate supplier partnerships.
Patent CN114075258B reveals a novel iodine-free route for hydrocortisone production, offering superior purity over 99.5% and streamlined manufacturing for global supply chains.
Advanced process for 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one using Mg-Reformatsky and Ru-catalysis. Delivers cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102060780A details a high-yield synthesis of 2-aminobenzimidazole derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN109384789A enables room temperature synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally. Offers green chemistry solutions.
Novel (R)-ω-transaminase mutant enables high-conversion synthesis of Sitagliptin intermediates, offering cost-effective and scalable pharmaceutical manufacturing solutions.
Patent CN107641622B reveals efficient enzymatic hydrolysis of terephthalonitrile, offering cost reduction in pharmaceutical intermediate manufacturing with high substrate tolerance.
Patent CN107384887A reveals high-purity Sitagliptin synthesis via aminotransferase. Achieves 99% ee and 76% yield, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111411094B discloses a novel mutant enzyme achieving 95.4% conversion at high substrate concentrations, offering significant cost reduction in API manufacturing.
Patent CN108866021B details a novel transaminase mutant for synthesizing sitagliptin intermediates with >99% ee. Discover cost-effective biocatalytic solutions for API manufacturing.